Caroline will have monthly blood and urine work at Vandy, and then is due back for another round of progress scans in October.
Thank you for all the support!
The Lantz Family
#carolinestrong
#ftgf
November 2017: diagnosed with Stage IV, High-Risk Neuroblastoma; Nov 2017-April 2019: completed standard treatment protocol / no evidence of disease; April 2019-April 2021: enrolled in/completed DFMO clinical trial; April 2022: RELAPSE; April 2022-June 2023: completed relapse treatment protocol / no evidence of disease (again); June 2023-June 2024: enrolled in “compassionate use” high-dose DFMO clinical trial; June 2024: RELAPSE #2
Friday, July 19, 2019
Results: 3 Month Progress Scans Today
Caroline had her 3 month post-treatment progress CT and MIBG scans today at Vanderbilt, and we can happily report that she still has No Evidence of Disease! Both scans showed no signs of any tumors, so we will continue on the current path of daily doses of DFMO (clinical trial drug), to hopefully keep the cancer away!
Caroline will have monthly blood and urine work at Vandy, and then is due back for another round of progress scans in October.
Thank you for all the support!
The Lantz Family
#carolinestrong
#ftgf
Caroline will have monthly blood and urine work at Vandy, and then is due back for another round of progress scans in October.
Thank you for all the support!
The Lantz Family
#carolinestrong
#ftgf
This is wonderful news!!
ReplyDeleteYayyyyy!!! Awesome news!!
ReplyDeleteFabulous news. So happy for you all!
ReplyDeleteAmen
ReplyDeleteSo glad to hear it!
ReplyDelete